Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Jasmine Wiley, M.D.
Family Practice · SHAWANO, WI · NPI 1568889020
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 504 | 127 |
| Lisinopril | Lisinopril | 411 | 111 |
| Amlodipine Besylate | Amlodipine Besylate | 326 | 82 |
| Metoprolol Succinate | Metoprolol Succinate | 326 | 86 |
| Warfarin Sodium | Warfarin Sodium | 313 | 27 |
| Levothyroxine Sodium | Levothyroxine Sodium | 308 | 85 |
| Losartan Potassium | Losartan Potassium | 264 | 67 |
| Gabapentin | Gabapentin | 255 | 65 |
| Omeprazole | Omeprazole | 254 | 71 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 250 | 68 |
| Furosemide | Furosemide | 214 | 62 |
| Simvastatin | Simvastatin | 194 | 52 |
| Metformin Hcl Er | Metformin Hcl | 191 | 52 |
| Potassium Chloride | Potassium Chloride | 180 | 43 |
| Famotidine | Famotidine | 179 | 45 |
| Eliquis | Apixaban | 175 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 174 | 54 |
| Metoprolol Tartrate | Metoprolol Tartrate | 160 | 38 |
| Duloxetine Hcl | Duloxetine Hcl | 158 | 38 |
| Sertraline Hcl | Sertraline Hcl | 144 | 34 |
| Pantoprazole Sodium | Pantoprazole Sodium | 133 | 52 |
| Alprazolam | Alprazolam | 109 | 27 |
| Buspirone Hcl | Buspirone Hcl | 109 | 21 |
| Prednisone | Prednisone | 106 | 70 |
| Metformin Hcl | Metformin Hcl | 105 | 32 |
| Jardiance | Empagliflozin | 103 | 23 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 102 | 35 |
| Trulicity | Dulaglutide | 102 | 21 |
| Alendronate Sodium | Alendronate Sodium | 101 | 27 |
| Allopurinol | Allopurinol | 99 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 97 | 54 |
| Spironolactone | Spironolactone | 94 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 94 | 26 |
| Trazodone Hcl | Trazodone Hcl | 89 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 87 | 22 |
| Donepezil Hcl | Donepezil Hcl | 86 | 12 |
| Montelukast Sodium | Montelukast Sodium | 85 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 83 | 35 |
| Mirtazapine | Mirtazapine | 80 | 15 |
| Carvedilol | Carvedilol | 78 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 77 | 21 |
| Baclofen | Baclofen | 67 | 12 |
| Memantine Hcl | Memantine Hcl | 64 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 60 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 60 | 15 |
| Cephalexin | Cephalexin | 59 | 47 |
| Paroxetine Hcl | Paroxetine Hcl | 58 | 12 |
| Tramadol Hcl | Tramadol Hcl | 58 | 33 |
| Xarelto | Rivaroxaban | 58 | 11 |
| Bupropion Xl | Bupropion Hcl | 57 | 18 |
| Atenolol | Atenolol | 56 | 17 |
| Ezetimibe | Ezetimibe | 56 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 52 | 14 |
| Finasteride | Finasteride | 51 | 15 |
| Synthroid | Levothyroxine Sodium | 50 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 48 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | 11 |
| Lorazepam | Lorazepam | 45 | 19 |
| Benazepril Hcl | Benazepril Hcl | 44 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | suppressed |
| Ozempic | Semaglutide | 44 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 43 | 20 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 43 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 42 | suppressed |
| Glipizide | Glipizide | 40 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 40 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 37 | suppressed |
| Chlorthalidone | Chlorthalidone | 36 | suppressed |
| Celecoxib | Celecoxib | 35 | 19 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 35 | 30 |
| Clonazepam | Clonazepam | 34 | suppressed |
| Glipizide Er | Glipizide | 34 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 23 |
| Amitriptyline Hcl | Amitriptyline Hcl | 32 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 23 |
| Ondansetron Odt | Ondansetron | 29 | 20 |
| Propranolol Hcl | Propranolol Hcl | 29 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Pregabalin | Pregabalin | 28 | suppressed |
| Amoxicillin | Amoxicillin | 27 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 27 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | 14 |
| Nystatin | Nystatin | 25 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 25 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 24 | 13 |
| Fentanyl | Fentanyl | 23 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 22 | suppressed |
| Topiramate | Topiramate | 22 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 20 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Latanoprost | Latanoprost | 20 | suppressed |
| Sucralfate | Sucralfate | 20 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 19 | suppressed |
| Meloxicam | Meloxicam | 19 | suppressed |
| Brilinta | Ticagrelor | 18 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 17 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Repaglinide | Repaglinide | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Digoxin | Digoxin | 15 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 15 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 15 | suppressed |
| Azithromycin | Azithromycin | 14 | 13 |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 14 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 13 |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Exelon | Rivastigmine | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | 12 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 12 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Diphenhydramine Hcl | Diphenhydramine Hcl | 11 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error